Page 36 - TD-2-3

Tumor Discovery Targeted drug delivery systems for the treatment of tumors

quantum dots-siRNA nanoplexes for gene silencing in Biol Appl, 84: 108–117.
tumor cells. Biomater Sci, 3: 192–202.
https://doi.org/10.1016/j.msec.2017.11.040
162. Wu CH, Cao C, Kim JH, et al., 2012, Trojan-horse nanotube
on-command intracellular drug delivery. Nano Lett, 168. Liu J, Wang B, Hartono SB, et al., 2012, Magnetic silica
12: 5475–5480. spheres with large nanopores for nucleic acid adsorption
and cellular uptake. Biomaterials, 33: 970–978.
https://doi.org/10.1021/nl301865c
https://doi.org/10.1016/j.biomaterials.2011.10.001
163. Gong H, Peng R, Liu Z, 2013, Carbon nanotubes for
biomedical imaging: The recent advances. Adv Drug Deliv 169. Wu P, Zhao T, Wang S, et al., 2014, Semiconductor quantum
Rev, 65: 1951–1963. dots-based metal ion probes. Nanoscale, 6: 43–64.
https://doi.org/10.1016/j.addr.2013.10.002 170. Nifontova G, Ramos GF, Baryshnikova M, et al., 2019,
Cancer cell targeting with functionalized quantum dot-
164. Cheng J, Meziani MJ, Sun YP, et al., 2011, Poly (ethylene encoded polyelectrolyte microcapsules. Front Chem, 7: 34.
glycol)-conjugated multi-walled carbon nanotubes as an
efficient drug carrier for overcoming multidrug resistance. https://doi.org/10.3389/fchem.2019.00034
Toxicol Appl Pharmacol, 250: 184–193.
171. AbdElhamid AS, Zayed DG, Helmy MW, et al., 2018,
https://doi.org/10.1016/j.taap.2010.10.012 Lactoferrin-tagged quantum dots-based theranostic
165. Lee CH, Cheng SH, Wang YJ, et al., 2009, Near-infrared nanocapsules for combined COX-2 inhibitor/herbal therapy
mesoporous silica nanoparticles for optical imaging: of breast cancer. Nanomedicine (Lond), 13: 2637–2656.
Characterization and in vivo biodistribution. Adv Funct https://doi.org/10.2217/nnm-2018-0196
Mater, 19: 215–222.
172. He H, Xie C, Ren J, 2008, Nonbleaching fluorescence of gold
166. Gao Y, Chen Y, Ji X, et al., 2011, Controlled intracellular nanoparticles and its applications in cancer cell imaging.
release of doxorubicin in multidrug-resistant cancer Anal Chem, 80: 5951–5957.
cells by tuning the shell-pore sizes of mesoporous silica
nanoparticles. ACS Nano, 5: 9788–9798. https://doi.org/10.1021/ac8005796
https://doi.org/10.1021/nn2033105 173. Albertini B, Mathieu V, ci N, et al., 2019, Tumor targeting
by peptide-decorated gold nanoparticles. Mol Pharm,
167. Zhao P, Li L, Zhou S, et al., 2018, TPGS functionalized
mesoporous silica nanoparticles for anticancer drug delivery 16: 2430–2444.
to overcome multidrug resistance. Mater Sci Eng C Mater https://doi.org/10.1021/acs.molpharmaceut.9b00047

Volume 2 Issue 3 (2023) 30 https://doi.org/10.36922/td.1356